StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — U.S. Revenue ($M) ($M)

Medtronic Form 8-K U.S. Revenue Tables

QuarterlyAnnual
Latest, Q4 FY23
374
Period ended Apr 30, 2023
Change on a year earlier
+4.5%
358 in Q4 FY22
History
24 quarters
Since Q2 FY17
Sources
20
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRespiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — U.S. Revenue ($M) ($M)Year on yearSource
Q4 FY23Apr 30, 2023374+4.5%Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗
Q3 FY23Jan 31, 2023365-4.2%Medtronic SEC 8K_EARNINGS — FY2023Q3 (filed 2023-02-21) ↗
Q2 FY23Oct 31, 2022345-17.9%Medtronic SEC 8K_EARNINGS — FY2023Q2 (filed 2022-11-22) ↗
Q1 FY23Jul 31, 2022334-9.7%Medtronic SEC 8K_EARNINGS — FY2023Q1 (filed 2022-08-23) ↗
Q4 FY22Apr 30, 2022358-3.8%Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗
Q3 FY22Jan 31, 2022381-9.5%Medtronic SEC 8K_EARNINGS — FY2023Q3 (filed 2023-02-21) ↗
Q2 FY22Oct 31, 2021420-3.7%Medtronic SEC 8K_EARNINGS — FY2023Q2 (filed 2022-11-22) ↗
Q1 FY22Jul 31, 2021370+14.9%Medtronic SEC 8K_EARNINGS — FY2023Q1 (filed 2022-08-23) ↗
Q4 FY21Apr 30, 2021372+6.0%Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗
Q3 FY21Jan 31, 2021421+21.7%Medtronic SEC 8K_EARNINGS — FY2022Q3 (filed 2022-02-22) ↗
Q2 FY21Oct 31, 2020436+29.0%Medtronic SEC 8K_EARNINGS — FY2022Q2 (filed 2021-11-23) ↗
Q1 FY21Jul 31, 2020322-5.3%Medtronic SEC 8K_EARNINGS — FY2022Q1 (filed 2021-08-24) ↗
Q4 FY20Apr 30, 2020351-3.0%Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗
Q3 FY20Jan 31, 2020346+1.5%Medtronic SEC 8K_EARNINGS — FY2021Q3 (filed 2021-02-23) ↗
Q2 FY20Oct 31, 2019338+8.7%Medtronic SEC 8K_EARNINGS — FY2021Q2 (filed 2020-11-24) ↗
Q1 FY20Jul 31, 2019340+13.0%Medtronic SEC 8K_EARNINGS — FY2021Q1 (filed 2020-08-25) ↗

Cite this data

StockData. (2026). Medtronic Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — U.S. Revenue ($M) ($M), quarterly Q2 FY17–Q4 FY23 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ms-rgr-leg-us-rev

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.